Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Grand Pharmaceutical Group Limited ( (HK:0512) ) has issued an announcement.
Grand Pharmaceutical Group Limited announced a restructuring of its shareholding, with Outwit Investments Limited acquiring additional shares from East Ocean Capital, increasing its stake to 53.42% of the company’s total issued share capital. This internal restructuring, involving entities ultimately controlled by Beijing Huachuang, does not change the ultimate control of the company, and a waiver was obtained to avoid a general offer under the Hong Kong Code on Takeovers and Mergers.
More about Grand Pharmaceutical Group Limited
Grand Pharmaceutical Group Limited operates in the pharmaceutical industry, focusing on the development and distribution of medical products. The company is involved in various segments of the healthcare market and is known for its extensive portfolio of pharmaceutical products.
Average Trading Volume: 33,669,320
Technical Sentiment Signal: Buy
Current Market Cap: HK$32.48B
For an in-depth examination of 0512 stock, go to TipRanks’ Overview page.